Publications by authors named "Markus Sachs"

Claim this Profile
U
Use of the Prostate Health Index and Density in 3 Outpatient Centers to Avoid Unnecessary Prostate Biopsies.
Anni Schulze, Frank Christoph, Markus Sachs, Joerg Schroeder, Carsten Stephan

Urol Int· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TP53 gene mutations in prostate cancer progression.
Thorsten H Ecke, Horst H Schlechte, Katrin Schiemenz, Markus D Sachs, Severin V Lenk

Anticancer Res· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TP53 gene mutations as an independent marker for urinary bladder cancer progression.
Thorsten H Ecke, Markus D Sachs, Severin V Lenk, Stefan A Loening, Horst H Schlechte

Int J Mol Med· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Valproic acid, a histone deacetylase inhibitor, is an antagonist for oncolytic adenoviral gene therapy.
Naseruddin Höti, Wasim Chowdhury, Jer-Tsong Hsieh, Markus D Sachs, Shawn E Lupold

Mol Ther· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Valproic acid inhibits invasiveness in bladder cancer but not in prostate cancer cells.
Chien-Lun Chen, Jennifer Sung, Michael Cohen, Wasim H Chowdhury, Markus D Sachs

J Pharmacol Exp Ther· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical value of vesical leukoplakia and evaluation of the neoplastic risk by mutation analyses of the tumor suppressor gene TP53.
Andrea Staack, Horst Schlechte, Markus Sachs, Glen Kristiansen, Mick Burkhardt

Int J Urol· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and validation of suitable endogenous reference genes for gene expression studies of human bladder cancer.
Falk Ohl, Monika Jung, Aleksandar Radonić, Markus Sachs, Stefan A Loening

J Urol· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term benefit of 5-aminolevulinic acid fluorescence assisted transurethral resection of superficial bladder cancer: 5-year results of a prospective randomized study.
Dmitry I Daniltchenko, Claus R Riedl, Markus D Sachs, Frank Koenig, Kurosch L Daha

J Urol· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of weekly paclitaxel and carboplatin chemotherapy in patients with advanced transitional cell cancer.
Manfred Johannsen, Markus Sachs, Jan Roigas, Axel Hinke, Andrea Staack

Eur Urol· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Histone deacetylase inhibitors upregulate expression of the coxsackie adenovirus receptor (CAR) preferentially in bladder cancer cells.
Markus D Sachs, Meera Ramamurthy, Henk van der Poel, Thomas J Wickham, Martine Lamfers

Cancer Gene Ther· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrin alpha(v) and coxsackie adenovirus receptor expression in clinical bladder cancer.
Markus D Sachs, Katherine A Rauen, Meera Ramamurthy, Jennifer L Dodson, Angelo M De Marzo

Urology· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis